title: Neonatal screening for cystic fibrosis.
abstract: Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.
authors.affiliation: Neonatal Screening Laboratory, State Department of Health, Royal Children's Hospital, Brisbane, Australia.
authors.forename: F
authors.initials: F
authors.lastname: Bowling
authors.forename: G
authors.initials: G
authors.lastname: Cleghorn
authors.forename: A
authors.initials: A
authors.lastname: Chester
authors.forename: J
authors.initials: J
authors.lastname: Curran
authors.forename: B
authors.initials: B
authors.lastname: Griffin
authors.forename: J
authors.initials: J
authors.lastname: Prado
authors.forename: P
authors.initials: P
authors.lastname: Francis
authors.forename: R
authors.initials: R
authors.lastname: Shepherd
mesh_terms: D001835:Body Weight; D003550:Cystic Fibrosis / Q000150:complications / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D011793:Queensland; D013997:Time Factors